CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…
DUNEDIN, FL / ACCESSWIRE / April 19, 2022 / Sean Hӓgen, BlӓckHagen Design Principal, Founder, and Director of Synthesis, will…
HAMILTON, BERMUDA / ACCESSWIRE / April 19, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and…
ENGLEWOOD, CO / ACCESSWIRE / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…
MINNEAPOLIS, MN / ACCESSWIRE / April 19, 2022 / PetVivo Holdings, Inc. (NASDAQ:PETV)(NASDAQ:PETVW) ("PetVivo") an emerging biomedical device company focused…
LOS ANGELES, CA / ACCESSWIRE / April 19, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,…
Moderna's first bivalent booster vaccine candidate, mRNA-1273.211, demonstrated superior neutralizing titers compared to mRNA-1273 against all variants of concern, including…
Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical EducationOAKVILLE, ON / ACCESSWIRE / April…
WOBURN, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its…